Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group. Hanauer SB, et al. Lancet. 2002 May 4;359(9317):1541-9. doi: 10.1016/S0140-6736(02)08512-4. Lancet. 2002. PMID: 12047962 Clinical Trial.
The role of mesalazine in Crohn's disease.
Hanauer SB. Hanauer SB. Scand J Gastroenterol Suppl. 1990;172:56-9. doi: 10.3109/00365529009091912. Scand J Gastroenterol Suppl. 1990. PMID: 1972296 Review.
Medical therapy of ulcerative colitis.
Hanauer SB. Hanauer SB. Lancet. 1993 Aug 14;342(8868):412-7. doi: 10.1016/0140-6736(93)92819-f. Lancet. 1993. PMID: 8101907 Review. No abstract available.
Medical management of perianal Crohn's disease.
Winter AM, Hanauer SB. Winter AM, et al. Among authors: hanauer sb. Semin Gastrointest Dis. 1998 Jan;9(1):10-4. Semin Gastrointest Dis. 1998. PMID: 9547851 Review.
Infliximab for the treatment of fistulas in patients with Crohn's disease.
Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ. Present DH, et al. Among authors: hanauer sb. N Engl J Med. 1999 May 6;340(18):1398-405. doi: 10.1056/NEJM199905063401804. N Engl J Med. 1999. PMID: 10228190 Free article. Clinical Trial.
Updating the approach to Crohn's disease.
Hanauer SB. Hanauer SB. Hosp Pract (1995). 1999 Aug 15;34(8):77-8, 81-3, 87-93; discussion 94. doi: 10.1080/21548331.1999.11443892. Hosp Pract (1995). 1999. PMID: 10459364
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR, Hanauer SB, McDonald JW, Feagan BG, Fedorak RN, Isaacs KL, Pike MG, Mays DC, Lipsky JJ, Gordon S, Kleoudis CS, Murdock RH Jr. Sandborn WJ, et al. Among authors: hanauer sb. Gastroenterology. 1999 Sep;117(3):527-35. doi: 10.1016/s0016-5085(99)70445-2. Gastroenterology. 1999. PMID: 10464128 Clinical Trial.
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
Rutgeerts P, D'Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, Mayer L, Van Hogezand RA, Braakman T, DeWoody KL, Schaible TF, Van Deventer SJ. Rutgeerts P, et al. Among authors: hanauer sb. Gastroenterology. 1999 Oct;117(4):761-9. doi: 10.1016/s0016-5085(99)70332-x. Gastroenterology. 1999. PMID: 10500056 Clinical Trial.
547 results